瘤微环境中的氨酸竞争:癌症治疗的潜在目标
Junlei Zhang1, Sijie Wang1, Huihui Liu1
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Medicinal research reviews
|October 7, 2025
概括
瘤细胞会造成阿尔金因缺乏,阻碍抗瘤免疫力. 本综述探讨了瘤微环境 (TME) 中的氨酸代谢,以优化氨酸缺乏和癌症治疗的补充疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 氨酸对免疫细胞的功能和增殖至关重要.
- 瘤细胞和免疫抑制细胞在瘤微环境 (TME) 中超过抗瘤免疫细胞的竞争力.
- 这种阿基宁缺乏导致免疫耐受性和瘤进展.
研究的目的:
- 为了比较TME内的瘤和免疫细胞中的氨酸运输,合成和新陈代谢.
- 确定基于氨酸的癌症治疗的潜在治疗点.
- 审查当前的阿金宁剥夺和补充策略及其临床应用.
主要方法:
- 在不同类型的细胞中对阿尔金宁代谢途径的比较分析.
- 关于基于阿金的治疗方法的最新研究的文献综述.
- 收集和总结临床试验数据.
主要成果:
- 瘤细胞和免疫抑制细胞在TME中占主导地位.
- 氨酸代谢在瘤和免疫细胞之间呈现出明显的差异.
- 缺少氨酸和补充疗法显示出潜力,但需要优化理解.
结论:
- 了解TME中阿金宁代谢对于有效的癌症免疫疗法至关重要.
- 针对阿尔金因的运输,合成或代谢提供了有前途的治疗途径.
- 需要进一步的研究和临床试验来完善基于阿尔金因的癌症治疗方法.
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K